Sangamo Therapeutics
SGMO
#9721
Rank
NZ$0.12 B
Marketcap
NZ$0.30
Share price
-19.95%
Change (1 day)
-64.91%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2025 (TTM): NZ-$0.76

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$0.76. In 2024 the company made an earnings per share (EPS) of NZ-$0.88.

EPS history for Sangamo Therapeutics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.76-12.93%
2024NZ-$0.88
2022NZ-$2.150.81%
2021NZ-$2.1333.33%
2020NZ-$1.606.9%
2019NZ-$1.5022.54%
2018NZ-$1.221.43%
2017NZ-$1.20-31.37%
2016NZ-$1.7575.86%
2015NZ-$1.0048.72%
2014NZ-$0.67-17.02%
2013NZ-$0.819.3%
2012NZ-$0.74-39.44%
2011NZ-$1.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.01-2,085.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.88-3,390.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$16.07-2,225.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ-$6.86 806.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.77-1,656.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.11-908.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$6.51-961.36%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.41-418.18%๐Ÿ‡บ๐Ÿ‡ธ USA